1. 1. Siegel R, Naishadham D, and Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 63: 11–30. 2013.
2. 2. Matsuda T, Marugame T, Kamo K, Katanoda K, Ajiki W, and Sobue T. Cancer incidence and incidence rates in Japan in 2006: Based on data from 15 population-based cancer registries in the monitoring of cancer incidence in Japan (MCIJ) project. Jpn J Clin Oncol. 42: 139–147. 2012.
3. 3. Zhang J, Dhakal IB, Zhao Z, and Li L. Trends in mortality from cancers of the breast, colon, prostate, esophagus, and stomach in East Asia: role of nutrition transition. Eur J Cancer Prev. 21: 480–489. 2012.
4. 4. Shirai T, Fukushima S, Ikawa E, Tagawa Y, and Ito N. Induction of prostate carcinoma in situ at high incidence in F344 rats by a combination of 3,2’-dimethyl-4-aminobiphenyl and ethinyl estradiol. Cancer Res. 46: 6423–6426. 1986.
5. 5. Shirai T, Tamano S, Kato T, Iwasaki S, Takahashi S, and Ito N. Induction of invasive carcinomas in the accessory sex organs other than the ventral prostate of rats given 3,2’-dimethyl-4-aminobiphenyl and testosterone propionate. Cancer Res. 51: 1264–1269. 1991.